↓ Skip to main content

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silicobased mechanism

Overview of attention for article published in Breast Cancer Research, May 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
94 Mendeley
Title
Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silicobased mechanism
Published in
Breast Cancer Research, May 2011
DOI 10.1186/bcr2888
Pubmed ID
Authors

Gloria Fuentes, Maurizio Scaltriti, José Baselga, Chandra S Verma

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Unknown 93 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 33 35%
Student > Ph. D. Student 19 20%
Professor > Associate Professor 7 7%
Other 6 6%
Student > Bachelor 4 4%
Other 15 16%
Unknown 10 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 28 30%
Biochemistry, Genetics and Molecular Biology 16 17%
Medicine and Dentistry 12 13%
Chemistry 7 7%
Pharmacology, Toxicology and Pharmaceutical Science 7 7%
Other 12 13%
Unknown 12 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2020.
All research outputs
#5,611,796
of 25,837,817 outputs
Outputs from Breast Cancer Research
#674
of 2,078 outputs
Outputs of similar age
#27,912
of 125,655 outputs
Outputs of similar age from Breast Cancer Research
#9
of 21 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,078 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.3. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 125,655 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.